封面
市场调查报告书
商品编码
1478061

全球自动化细胞成像系统市场规模、份额、成长分析、按产品、最终用户、应用、技术、地区 - 产业预测,2024-2031

Global Automated Cell Imaging System Market Size, Share, Growth Analysis, By Product, By End users, By Application, By Technology, By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格
简介目录

自动化细胞成像系统的全球市场规模到2022年将达到1089亿美元,从2023年的1183.7亿美元增长到2031年的2307.2亿美元,预计在预测期内(2024-2031年)将以复合年增长率增长。

预计市场将以更快、更健康的速度扩张。因为世界上患有慢性病的人比以往任何时候都多。此外,加大新药、疫苗研发投入也支持市场拓展。然而,由于高昂的维护成本和缺乏更换零件,自动细胞成像系统的市场并未如预期扩大。从全球来看,北美所占比例最高。这得益于医疗产业较早采用最尖端科技。美国是这一领域的领先国家。由于医疗保健领域的大量投资,亚太地区正在迅速扩张。

目录

执行摘要

  • 市场概况
  • 升起和降落

调查方法

  • 资讯采购
  • 二手资料来源和主要资料来源
  • 市场规模预测
  • 市场危机与限制

母市场分析

  • 市场概况
  • 市场规模
  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务

主要市场考察

  • 技术分析
  • 价格分析
  • 供应链分析
  • 价值链分析
  • 市场生态系统
  • 智慧财产权分析
  • 贸易分析
  • Start-Ups分析
  • 原料分析
  • 创新矩阵
  • 研发线产品分析
  • 宏观经济指标
  • 主要投资分析
  • 关键成功因素
  • 竞争程度

市场动态及展望

  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
  • 监管环境
  • 波特的分析
  • 对未来中断的特殊考虑

自动化细胞成像系统的全球市场:副产品

  • 市场概况
  • 时间流逝
  • 共定位
  • 其他的

全球自动化细胞成像系统市场:依最终用户分类

  • 市场概况
  • 医院
  • 研究和诊断实验室

自动细胞影像系统的全球市场:按应用分类

  • 市场概况
  • 活细胞生物成像
  • 筛检

自动化细胞成像系统的全球市场:按技术分类

  • 市场概况
  • 萤光
  • 发光
  • 相差
  • 其他的

全球自动化细胞成像系统市场:按地区

  • 市场概况
  • 亚太地区
  • 欧洲
  • 北美洲
  • 中东/非洲
  • 拉丁美洲

自动化细胞成像系统的全球市场规模:按地区

  • 市场概况
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东/非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲地区

竞争格局

  • 前5名企业对比
  • 主要企业市场定位(2023年)
  • 主要市场参与者所采取的策略
  • 关键成功策略
  • 近期市集活动
  • 主要企业市场占有率(2023年)

主要企业简介

  • Thermo Fisher Scientific Inc.
  • Carl Zeiss AG
  • Olympus Corporation
  • GE Healthcare
  • Leica Microsystems GmbH
  • PerkinElmer, Inc.
  • Nikon Corporation
  • Molecular Devices LLC
  • BD Biosciences
  • BioTek Instruments, Inc.
  • Sartorius AG
  • Agilent Technologies, Inc.
  • Tecan Group AG
  • Bruker Corporation
  • Merck KGaA
  • Yokogawa Electric Corporation
  • Hamilton Company
  • Danaher Corporation
  • Sysmex Corporation
  • Bio-Rad Laboratories, Inc.
简介目录
Product Code: SQMIG35J2035

Global Automated Cell Imaging System Market size was valued at USD 108.9 billion in 2022 and is poised to grow from USD 118.37 billion in 2023 to USD 230.72 billion by 2031, growing at a CAGR of 8.7% during the forecast period (2024-2031).

The market is anticipated to expand more quickly and at a healthier rate. It is because there are more chronic patients in the world than ever before. The expansion of the market is also being driven by increased investments in research and development of novel medications and vaccines. Nevertheless, the market for automated cell imaging systems is not expanding as quickly as it should due to high maintenance costs and a lack of replacement parts. Globally, North America has the largest proportion. The early adoption of cutting-edge technologies in the healthcare industry is to blame. The United States is the main nation in the area. Due to significant investment in the healthcare sector, the Asia-Pacific area is expanding at a quicker rate.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Automated Cell Imaging System Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the Market size includes the following details: The key players in the Market were identified through secondary research, and their Market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top Market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Automated Cell Imaging System Market Segmental Analysis

The global automated cell imaging system is categorized on the basis of product, end-user, technology, and region. With respect to segmentation by product, the market is grouped into time lapse, colocalization, and others. In terms of classification by end user, the market is segmented into hospitals, and research and diagnostic laboratories. On the basis of application, the market is segmented into live cell vivo imaging, and screening. Based on technology, the market is classified into fluorescence, luminescence, phase contrast, and others. Geographically, the market is segmented into Asia Pacific, Europe, North America, Middle East & Africa, and Latin America.

Drivers of the Global Automated Cell Imaging System Market

Our body exhibits certain genetic abnormalities as a result of radiation and lifestyle changes. This results in aberrant cell division, which causes tumors. Cancer is also brought on by specific chemicals that are exposed to food, water, and soil. In order to determine the dynamics and activities of telomeric repeat-containing RNA, automated cell imaging methods are also necessary for the development of novel cancer kinds. With the ability to examine digitized microscopic images of malignant cells, automated cell imaging is a novel and increasingly popular method for cellular research.

Restraints in the Global Automated Cell Imaging System Market

When an automated cell imaging system is destroyed, its spare parts must be completely replaced, which comes at a very high cost. It's because there is a supply side shortfall caused by the small number of manufacturers of this product. Additionally, the setup costs are relatively significant. Its operation also necessitates considerable electricity.

Market Trends of the Global Automated Cell Imaging System Market

Large pharmaceutical companies are heavily investing in new technology in an effort to develop new medications and vaccines. In long-term experiments, huge chemical libraries, or both, automated cell imaging methods reduce human error and the amount of time required for human intervention. High-resolution photos are collected and analyzed by the system.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Automated Cell Imaging System Market by Product

  • Market Overview
  • Time Lapse
  • and Colocalization
  • and Others

Global Automated Cell Imaging System Market by End users

  • Market Overview
  • Hospitals
  • Research and Diagnostic Laboratories.

Global Automated Cell Imaging System Market by Application

  • Market Overview
  • Live Cell Vivo Imaging
  • and Screening.

Global Automated Cell Imaging System Market by Technology

  • Market Overview
  • Fluorescence
  • Luminescence
  • Phase Contrast
  • and Others

Global Automated Cell Imaging System Market by Region

  • Market Overview
  • Asia Pacific
  • Europe
  • North America
  • Middle East & Africa
  • and Latin America

Global Automated Cell Imaging System Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Carl Zeiss AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Olympus Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Leica Microsystems GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nikon Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Molecular Devices LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BD Biosciences
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioTek Instruments, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sartorius AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tecan Group AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Yokogawa Electric Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hamilton Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sysmex Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments